Bright Minds Biosciences (DRUG) Institutional Ownership $35.99 +1.19 (+3.42%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$35.29 -0.70 (-1.94%) As of 03/25/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Bright Minds Biosciences (NASDAQ:DRUG)CurrentInstitutional OwnershipPercentage40.52%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$68.55MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$6.46M Get DRUG Insider Trade Alerts Want to know when executives and insiders are buying or selling Bright Minds Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DRUG Institutional Buying and Selling by Quarter Remove Ads Bright Minds Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Point72 Asset Management L.P.135,189$4.87M0.0%N/A3.049% 2/17/2025 Millennium Management LLC40,379$1.45M0.0%N/A0.911% 2/17/2025 Janus Henderson Group PLC508,776$18.39M0.0%N/A11.485% 2/17/2025 Bank of America Corp DE4,793$173K0.0%N/A0.108% 2/17/2025 Acuta Capital Partners LLC69,124$2.49M2.5%N/A1.560% 2/14/2025 RA Capital Management L.P.460,829$16.60M0.2%N/A10.402% 2/14/2025 Jane Street Group LLC6,600$238K0.0%N/A0.149% 2/14/2025 Schonfeld Strategic Advisors LLC69,812$2.47M0.0%N/A1.576% 2/14/2025 AdvisorShares Investments LLC3,075$111K0.0%-98.3%0.069% 2/14/2025 Boothbay Fund Management LLC44,580$1.61M0.0%N/A1.006% 2/14/2025 Adage Capital Partners GP L.L.C.132,500$4.77M0.0%N/A2.991% 2/14/2025 Vivo Capital LLC251,572$9.06M1.0%N/A5.679% 2/13/2025 Walleye Capital LLC103,192$3.72M0.0%N/A2.327% 2/13/2025 Springhill Fund Asset Management HK Co Ltd60,648$2.19M3.5%N/A1.369% 2/13/2025 Atika Capital Management LLC15,000$540K0.1%N/A0.339% 2/14/2024 AdvisorShares Investments LLC188,119$273K0.1%+12.0%4.246% 11/6/2023 AdvisorShares Investments LLC167,930$267K0.1%-67.4%4.452% 8/9/2023 AdvisorShares Investments LLC515,315$294K0.1%+14.7%14.640% 5/9/2023 AdvisorShares Investments LLC449,155$198K0.1%+42.7%2.553% 8/8/2022 AdvisorShares Investments LLC289,576$237K0.1%+40.1%2.439% 5/9/2022 AdvisorShares Investments LLC206,716$314K0.1%+115.5%1.745% 2/9/2022 Checchi Capital Advisers LLC14,138$45K0.0%N/A0.119% 1/31/2022 AdvisorShares Investments LLC95,942$304K0.0%N/A0.810% (Data available from 1/1/2016 forward)Remove Ads DRUG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DRUG shares? During the previous two years, 15 institutional investors and hedge funds held shares of Bright Minds Biosciences. The most heavily invested institutionals were Janus Henderson Group PLC ($18.39M), RA Capital Management L.P. ($16.60M), Vivo Capital LLC ($9.06M), Point72 Asset Management L.P. ($4.87M), Adage Capital Partners GP L.L.C. ($4.77M), Walleye Capital LLC ($3.72M), and Acuta Capital Partners LLC ($2.49M).Learn more on DRUG's institutional investors. What percentage of Bright Minds Biosciences stock is owned by institutional investors? 40.52% of Bright Minds Biosciences stock is owned by institutional investors. Learn more on DRUG's institutional investor holdings. Which institutional investors have been buying Bright Minds Biosciences stock? Of the 15 institutional investors that purchased Bright Minds Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($508.78K), RA Capital Management L.P. ($460.83K), Vivo Capital LLC ($251.57K), AdvisorShares Investments LLC ($220.64K), Point72 Asset Management L.P. ($135.19K), Adage Capital Partners GP L.L.C. ($132.50K), and Walleye Capital LLC ($103.19K). How much institutional buying is happening at Bright Minds Biosciences? Institutional investors have bought a total of 2,123,635 shares in the last 24 months. This purchase volume represents approximately $69.06M in transactions. Which Bright Minds Biosciences major shareholders have been selling company stock? The following institutional investors have sold Bright Minds Biosciences stock in the last 24 months: AdvisorShares Investments LLC ($526.73K). How much institutional selling is happening at Bright Minds Biosciences? Institutional investors have sold a total of 526,730 shares in the last 24 months. This volume of shares sold represents approximately $7.02M in transactions. Related Companies Intellia Therapeutics Institutional Ownership Arcus Biosciences Institutional Ownership Vir Biotechnology Institutional Ownership Rocket Pharmaceuticals Institutional Ownership Collegium Pharmaceutical Institutional Ownership Xencor Institutional Ownership Replimune Group Institutional Ownership Phibro Animal Health Institutional Ownership Day One Biopharmaceuticals Institutional Ownership Zymeworks Institutional Ownership This page (NASDAQ:DRUG) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRUG Stock Free DRUG Stock Alerts